Studies on gynaecological hydrophilic lactic acid preparations. Part 5: The use of Eudragit E-100 as lactic acid carrier in intravaginal tablets.
K Małolepsza-Jarmołowska, A A Kubis, L Hirnle
Index: Pharmazie 58(4) , 260-2, (2003)
Full Text: HTML
Abstract
Intravaginal tablets based on hydrophilic methylcellulose and containing lactic acid complexed with Eudragit E-100 undergo deformation under standard conditions. The high flow--limit of gel originating from the tablets as well as its dynamic viscosity should enable durability of this dosage form on the vaginal mucosa. By selecting either 1 : 1 or 2 : 1 ratios of lactic acid to Eudragit E-100 it is possible to obtain tablets that disintegrate into a gelform at pH 3.8-4.4, i.e. the pH remains within the physiological range. Increasing the amount of lactic acid in the complex in relation to the polymer to a 4:1 ratio results in gels with a lower pH while possessing an acid reserve that can neutralize the excess of alkali present in severe vaginal infections.
Related Compounds
Related Articles:
Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.
2012-01-01
[Chem. Pharm. Bull. 60(11) , 1468-73, (2012)]
2013-11-01
[Drug Dev. Ind. Pharm. 39(11) , 1698-705, (2013)]
2007-01-01
[AAPS PharmSciTech 8(2) , Article 34, (2007)]
2013-06-01
[Drug Res. (Stuttg.) 63(6) , 326-30, (2013)]
2002-01-01
[AAPS PharmSciTech 3(4) , E33, (2002)]